Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Antonio Giordano, Md

Clinical trials sponsored by Antonio Giordano, Md, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug combo aims to shrink tough breast cancer tumors Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New drug combo aims to shrink tough breast cancer tumors

Disease control Ongoing

This study tests whether adding the experimental drug onvansertib to standard chemotherapy (paclitaxel) can safely shrink tumors in people with triple-negative breast cancer that has spread. About 50 adults with advanced or metastatic disease will receive the combination. The goa…

Phase 1/2 • Sponsor: Antonio Giordano, MD • Aim: Disease control

Last updated Jun 27, 2026 09:04 UTC